Calculated based on number of publications stored in Pure and citations from Scopus
20252025

Research activity per year

Personal profile

Personal profile

Modernization of traditional Chinese herbal medicines

Quality formation mechanisms

Origin tracing model

Currently, the main focus is on the prevention and treatment of MAFLD(metabolic associated fatty liver disease), hyperlipidemia, and cardiovascular and cerebrovascular diseases.

中药材现代化开发

道地药材和道地产区评价

药材产地溯源和品质形成机制

近期研究:天然产物对代谢性脂肪肝病的治疗

Experience

Research Project/Funding experience

National Key R&D Program Project "Modernization of Chinese Medicinal Materials" 2020 - Key Member (Project Executor) of the project "Lithocarpus Litseifolius"

科研项目经验

国家重点研发计划项目“中医药现代化研究”课题“木姜叶柯”子课题骨干(课题执行),承担单位

标准申报

主导申报省级标准两项,企业标准一项:

《江苏省中药材标准》“木姜叶柯” 2016版

《湖南省中药材标准》“木姜叶柯” 2022版

《湖南省企业标准》“木姜叶柯” 2021年

专利情况

发明专利申报3项,实用新型专利12项。申请注册商标3项。软件著作权1项。

中药材种植、研发、生产规模化

现已建设投成:

芷江乐甜沙湾标准化示范种植基地

总面积1500亩,目前使用面积500亩

芷江工业园区甜茶生产工厂

面积4000平。药材年初级处理能力1000吨,生产能力200吨。包含揉捻、烘干、分装、包装、粉碎、发酵等能力。

芷江甜茶园质量检验实验室

HPLC, 药材理化性质(水分、灰分、浸出物、总多糖、总黄酮、茶多酚、咖啡因、游离氨基酸、游离脂肪酸)

江苏常州武进区重点实验室“木姜叶柯育种与加工实验室”

HPLC, 药材理化性质(水分、灰分、浸出物、总多糖、总黄酮、茶多酚、咖啡因、游离氨基酸、游离脂肪酸)

江西安福赤谷乡甜茶育种基地

面积500亩

欢迎有植物、农业实验需求的老师与我合作。

外部合作

中药I类开发 进入临床I期批件申请阶段

与中科院上海药物研究所签订“关于木姜叶柯总黄酮糖苷新药开发的合作” 2022-2030年

临床合作单位 

江苏省中医院 以中药材资源招标形式以及院内制剂形式 2018年-至今

研发合作单位

华东理工大学贺晓鹏团队

荧光分子探针

华东理工大学尚亚卓团队

化妆品开发

浙江省农业科学院农产品质量研究所

稳定同位素相关研究

上海药物所苏州研究院

动物研究

中国中医科学院中药研究所

中药材现代化研究

中南民族大学药学院

产学研合作

久瓴科技

数字孪生辅助种植采收研究、土壤质量评估研究

昆明植物所

种质研究

Standard Declaration:

Led the declaration of two provincial standards and one enterprise standard:

"Lithocarpus Litseifolius" in Jiangsu Provincial Standard of Chinese Materia Medica, 2016 Edition

"Lithocarpus Litseifolius" in Hunan Provincial Standard of Chinese Materia Medica, 2022 Edition

"Lithocarpus Litseifolius" in Hunan Enterprise Standard, 2021

Patent Status:

3 invention patent applications. 12 utility model patent applications. 3 trademark registration applications. 1 software copyright registration.

Large-scale Cultivation, Research & Development, and Production of Traditional Chinese Medicinal Materials:

Currently Established:

Zhijiang Letian Shawan Standardized Demonstration Cultivation Base, covering an area of 1500 mu (approximately 247 acres), with 500 mu (approximately 82 acres) currently in use.

Zhijiang Industrial Park Sweet Tea Production Factory, with an area of 4000 square meters. The factory has an initial processing capacity of 1000 tons of medicinal materials and a production capacity of 200 tons, including rolling, drying, sorting, packaging, pulverizing, and fermentation capabilities.

Zhijiang Sweet Tea Garden Quality Inspection Laboratory.

Key Laboratory in Wujin District, Changzhou, Jiangsu - Lithocarpus Litseifolius Breeding and Processing Laboratory.

Anfu Chigu Township Sweet Tea Breeding Base in Jiangxi, covering an area of 500 mu (approximately 82 acres).

Researchers with plant or agricultural experimental needs are welcome to collaborate.

External Collaborations:

Class I Traditional Chinese Medicine (Development Enters Phase I Clinical Trial Application Stage)

Collaboration agreement signed with Shanghai Institute of Materia Medica, Chinese Academy of Sciences, for the development of a novel drug based on Litsea Green Leaf Flavonoid Glycosides (2022-2030)

Clinical Collaboration Partner:

Jiangsu Provincial Hospital of Traditional Chinese Medicine: Through bidding for traditional Chinese medicine resources and in-house preparation formulations (2018-Present)

R&D Collaboration Partners:

He Xiaopeng Team, East China University of Science and Technology: Scientific research collaboration (fluorescent molecular probes)

Shang Yazhuo Team, East China University of Science and Technology: Product collaboration (cosmetics development)

Institute of Agro-Product Quality Standards and Testing Technology, Zhejiang Academy of Agricultural Sciences: Stable isotope-related research

Kunming Institute of Botany: Germplasm research

Suzhou Institute of Drug Discovery, Shanghai Institute of Materia Medica: Animal studies

Jiuling Technology: Digital twin-assisted planting and harvesting research, soil quality assessment research

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences: Modernization research of traditional Chinese medicines

School of Pharmaceutical Sciences, South-Central University for Nationalities: Industry-academia-research collaboration

Awards and honours

Academic Excellence Award - Griffith University 2019

湟里镇年度十佳志愿者

带领公司团队获得荣誉:

市级龙头企业 湖南省怀化市农业产业化

理事单位、优秀会员 湖南省怀化市茶文化促进会

理事单位 常州市第五届青年商会

一等奖 常州市第四届农村创业创新项目创意大赛(初创组) 

优胜奖 “溧水农商行杯”第五届江苏省农村创业创新项目创意大赛(初创组)

优质产品奖 第二届怀商大会

 

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Related documents

Education/Academic qualification

Master, Biomolecular Science, Griffith University

20192021

Bachelor, Biopharmaceutical, Nanjing University of Chinese Medicine

20152019

External positions

Chairman, Student-Staff Liaison Committee (AoP)

20242025

理事, 常州市青年科技人才协会

2024 → …

委员, 常州市青年联合会

20242029

主席团成员, 西浦慧湖生物医药学会

2024 → …

委员, 会员单位, 中国中药协会药食同源物质评价与利用专委会

2023 → …

镇秘书长, 欧美同学会

2023 → …

主任, 武进区重点实验室“木姜叶柯育种与加工”实验室

2023 → …

Executive Director, Liangtian biomedicine Technology Jiangsu Co., LTD.

2021 → …

Research areas

  • MAFLD
  • Modernization of Traditional Chineses Herbal Medicine

Person Types

  • Students

Fingerprint

Dive into the research topics where Yifan Tang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or